{"log_id": 639393397091200918, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 1.4e-05, "average": 0.997679, "min": 0.984637}, "location": {"width": 781, "top": 227, "height": 27, "left": 220}, "words": "作用的关系未能充分探讨,但一些患者对每天75m的剂量无效时可能在剂量提高到最大"}, {"probability": {"variance": 0, "average": 0.999909, "min": 0.999909}, "location": {"width": 25, "top": 225, "height": 24, "left": 1147}, "words": "证"}, {"probability": {"variance": 0.000179, "average": 0.993628, "min": 0.942255}, "location": {"width": 758, "top": 273, "height": 27, "left": 224}, "words": "225mg有效,因为大部分患者文拉法辛和主要代谢产物到第4天达到稳态浓度。如果必要"}, {"probability": {"variance": 0, "average": 0.898339, "min": 0.898339}, "location": {"width": 21, "top": 260, "height": 26, "left": 1144}, "words": "等"}, {"probability": {"variance": 0.000253, "average": 0.993503, "min": 0.908026}, "location": {"width": 779, "top": 319, "height": 26, "left": 221}, "words": "可以在4天以后在75mg日剂量上加量。在评估疗效的研究中,允许在2周以上时间进行药物"}, {"probability": {"variance": 0.001242, "average": 0.988857, "min": 0.836101}, "location": {"width": 321, "top": 365, "height": 26, "left": 221}, "words": "递增,平均剂量约为每天140~180mg"}, {"probability": {"variance": 0.002562, "average": 0.980576, "min": 0.780271}, "location": {"width": 571, "top": 410, "height": 27, "left": 259}, "words": "目前对较严重的抑郁症患者尚缺乏本品剂量高干每天225mg的经验"}, {"probability": {"variance": 3.5e-05, "average": 0.994111, "min": 0.982136}, "location": {"width": 122, "top": 457, "height": 24, "left": 221}, "words": "广泛性焦虑症"}, {"probability": {"variance": 0.001246, "average": 0.989656, "min": 0.81047}, "location": {"width": 520, "top": 501, "height": 24, "left": 261}, "words": "对于多数患者,推荐本品的起始剂量为每天75mg,单次服药"}, {"probability": {"variance": 0.016835, "average": 0.967849, "min": 0.391668}, "location": {"width": 738, "top": 545, "height": 25, "left": 263}, "words": "在本品治疗广泛性焦症疗效的临床研究中,起始剂量为每天75mg最大剂量为每天"}, {"probability": {"variance": 0.003587, "average": 0.979638, "min": 0.631629}, "location": {"width": 776, "top": 590, "height": 27, "left": 222}, "words": "225mg。对某些新发病患者,在调整剂量增至每日75mg前,可能更适于每日37.5mg起始治"}, {"probability": {"variance": 0.001002, "average": 0.990833, "min": 0.801688}, "location": {"width": 777, "top": 634, "height": 26, "left": 222}, "words": "疗4~7天。虽然在固定剂量的研究中未能明确证实治疗GAD的量效关系,但一些患者对每"}, {"probability": {"variance": 0.006118, "average": 0.974664, "min": 0.595385}, "location": {"width": 775, "top": 679, "height": 27, "left": 224}, "words": "天75mg的剂量无效时可能在剂量提高到约每天225mg有效,如果必要,可以在4天以后逐渐"}, {"probability": {"variance": 0, "average": 0.99975, "min": 0.999615}, "location": {"width": 40, "top": 726, "height": 22, "left": 222}, "words": "加量"}, {"probability": {"variance": 9e-06, "average": 0.997719, "min": 0.987327}, "location": {"width": 320, "top": 767, "height": 28, "left": 221}, "words": "从盐酸文拉法辛常释片换用缓释胶囊"}, {"probability": {"variance": 4.8e-05, "average": 0.996939, "min": 0.96754}, "location": {"width": 731, "top": 814, "height": 25, "left": 268}, "words": "当前应用盐酸文拉法辛常释片治疗的抑郁症患者可以换用每日治疗剂量几乎等同的本"}, {"probability": {"variance": 0.002234, "average": 0.980601, "min": 0.757172}, "location": {"width": 778, "top": 858, "height": 26, "left": 222}, "words": "品缓释胶囊,如服用37.5mg文拉法辛片每日两次,可换用75mg的本品,每日一次。必要时"}, {"probability": {"variance": 1e-06, "average": 0.999504, "min": 0.996768}, "location": {"width": 298, "top": 902, "height": 27, "left": 223}, "words": "需要根据患者的个体情况进行调整"}, {"probability": {"variance": 0, "average": 0.999837, "min": 0.9994}, "location": {"width": 82, "top": 948, "height": 24, "left": 222}, "words": "特殊人群"}, {"probability": {"variance": 0.000236, "average": 0.991297, "min": 0.946877}, "location": {"width": 249, "top": 992, "height": 24, "left": 225}, "words": "对孕期后3个月的孕妇的治疗"}, {"probability": {"variance": 0.008471, "average": 0.964187, "min": 0.566626}, "location": {"width": 736, "top": 1036, "height": 25, "left": 263}, "words": "在第7孕月以后暴露于本品、其它5-羟色胺和去甲肾上腺素再摄取抑制剂( SNRIS)和选"}, {"probability": {"variance": 0.028248, "average": 0.914309, "min": 0.371421}, "location": {"width": 776, "top": 1069, "height": 37, "left": 222}, "words": "择性5-羟色胺再摄取抑制剂(SSRs的新生儿,其需要呼吸支持、胃管喂养和延长院"}, {"probability": {"variance": 0.007602, "average": 0.9719, "min": 0.54667}, "location": {"width": 777, "top": 1122, "height": 30, "left": 222}, "words": "并发症的发生率增加(见【孕妇及哺乳期妇女用药】。在孕期的后3个月使用本品时医生"}, {"probability": {"variance": 0.001299, "average": 0.987507, "min": 0.862937}, "location": {"width": 258, "top": 1168, "height": 28, "left": 222}, "words": "仔细权衡利弊,需要考虑减量"}, {"probability": {"variance": 3.9e-05, "average": 0.99579, "min": 0.980803}, "location": {"width": 142, "top": 1215, "height": 23, "left": 225}, "words": "肝功能不全患者"}, {"probability": {"variance": 0.000486, "average": 0.981683, "min": 0.950596}, "location": {"width": 115, "top": 1166, "height": 107, "left": 893}, "words": "任公司"}, {"probability": {"variance": 0.001844, "average": 0.981817, "min": 0.799318}, "location": {"width": 738, "top": 1256, "height": 27, "left": 261}, "words": "肝硬化和轻至中度肝功能不全的患者与健康者相比,文拉法辛和O=去甲基文拉法辛"}, {"probability": {"variance": 0.003305, "average": 0.9748, "min": 0.744996}, "location": {"width": 755, "top": 1301, "height": 27, "left": 244}, "words": "ODV)的清除半衰期延长、清除率下降(见【药代动力学】),对于轻度至中度肝功能不"}, {"probability": {"variance": 0.000365, "average": 0.992006, "min": 0.896829}, "location": {"width": 778, "top": 1346, "height": 26, "left": 222}, "words": "全的患者每日总剂量必须减少50%。对于有些患者,甚至有必要将剂量减少50%以上。因为"}, {"probability": {"variance": 1.4e-05, "average": 0.997554, "min": 0.986083}, "location": {"width": 534, "top": 1389, "height": 31, "left": 222}, "words": "肝硬化患者的药物清除率有较大个体差异,个体化用药较合适"}, {"probability": {"variance": 7e-06, "average": 0.997789, "min": 0.991702}, "location": {"width": 142, "top": 1438, "height": 24, "left": 225}, "words": "肾功能不全患者"}, {"probability": {"variance": 0.014067, "average": 0.966011, "min": 0.401123}, "location": {"width": 732, "top": 1481, "height": 25, "left": 263}, "words": "肾功能不全患者(GFR=10~70m/min)与健康者相比,文拉法辛的清除率下降、文拉"}, {"probability": {"variance": 0.003728, "average": 0.974448, "min": 0.71355}, "location": {"width": 778, "top": 1524, "height": 25, "left": 222}, "words": "法辛和ODV的清除半衰期延长(见【药代动力学】),每日总剂量必须减少25%~50%。接"}], "language": 3}